Xpovio
Term · Oncology and biomedicine · MLC-T-ONC-009421
A drug used alone or with other drugs to treat adults with certain types of diffuse large B-cell lymphoma or multiple myeloma. It is used in patients whose cancer has already been treated with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Xpovio blocks a protein called CRM1, which may help keep cancer cells from growing and may kill them. It is a type of small molecule inhibitor. Also called selinexor.
| Identifier | MLC-T-ONC-009421 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | selinexor |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009421",
"term": "Xpovio",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat adults with certain types of diffuse large B-cell lymphoma or multiple myeloma. It is used in patients whose cancer has already been treated with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Xpovio blocks a protein called CRM1, which may help keep cancer cells from growing and may kill them. It is a type of small molecule inhibitor. Also called selinexor.",
"synonyms": [
"selinexor"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/xpovio/"
}
Record 17,513 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.